MAXIS Clinical’s Real World Evidence (RWE) Studies services leverages multi-sourced data collection model with advanced analytics tools to provide valuable insights beyond traditional clinical studies, better equipping decision-makers along this product lifecycle journey.
Deep knowledge base of data harmonization from a wide variety of sources, such as electronic health records, claims databases, and patient registries.
Tap into state-of-the-art statistical methods and machine learning algorithms that can derive meaningful insights from complex data sets.
Our pharmacists bring clinical precision to our solutions, focusing on patient outcomes.
Ensure that all RWE studies are in compliance with global regulatory standards and guidelines on the use of real-world data.
Our experts adeptly handle pricing and access challenges in diverse healthcare systems worldwide.
Assess data availability and quality to determine the feasibility of RWE studies and identify potential research questions.
Design and execute studies to evaluate treatment patterns, outcomes, and safety in real-world populations.
Conduct trials that balance internal validity with real-world applicability to inform clinical decision-making.
Compare the effectiveness of different interventions in real-world clinical practice to support value demonstration.
Investigate disease prevalence, incidence, and risk factors in defined populations to inform public health strategies.
Evaluate the economic impact of treatments and capture patient perspectives on health-related quality of life.
Monitor and assess the long-term safety profiles of medical products in diverse patient populations.
Are you looking to enhance your product's value proposition with robust real-world evidence? Our RWE Studies can help you: